US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Guardant Health, Inc. - Common Stock (NQ:GH)

177.80 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
News headline image
Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
From Guardant Health, Inc.
Via Business Wire
News headline image
Barron's Top Weekend Stock Picks: AMD, Ford, Accenture And Should Tesla CEO Elon Musk Be Replaced? ↗
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain ↗
The broader market lost more ground on Friday. 
Via The Motley Fool
8 Analysts Have This to Say About Guardant Health ↗
 
Via Benzinga
News headline image
Expert Ratings for Guardant Health ↗
 
Via Benzinga
News headline image
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
News headline image
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy? ↗
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing. 
Via InvestorPlace
News headline image
Why Is Exact Sciences (EXAS) Stock Up 23% Today? ↗
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected. 
Via InvestorPlace
News headline image
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results ↗
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket ↗
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday! 
Via InvestorPlace
News headline image
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today ↗
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the... 
Via Benzinga
News headline image
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard ↗
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test. 
Via Investor's Business Daily
News headline image
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? ↗
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Guardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
2 Top Healthcare Stocks to Buy for the Long Haul ↗
These two companies are just getting started. 
Via The Motley Fool
News headline image
Guardant Health Announces Collaboration With AstraZeneca to Develop Companion Diagnostic to Identify Patients With ESR1-mutated Metastatic Breast Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients
From Guardant Health, Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark ↗
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date. 
Via Benzinga
News headline image
Guardant Health Reports Third Quarter 2022 Financial Results
From Guardant Health, Inc.
Via Business Wire
News headline image
Where Guardant Health Stands With Analysts ↗
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why Guardant Health Stock Fell 5.5% Today ↗
Is Guardant Health as obvious a bargain as this analyst makes it out to be? 
Via The Motley Fool
News headline image
Guardant Health to Report Third Quarter 2022 Financial Results on November 3, 2022
From Guardant Health, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 ↗
Upgrades 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >